CHRM1 and neuropathy: We have previously reported that muscarinic antagonists that selectively or specifically target the M1 receptor sub-type (M1R) promote neurite growth in adult sensory neurons in vitro [41,42,43,44] and correct multiple indices of neuropathy when given systemically to diabetic rodents [41,45].